StockWatch
·

IRCON International Ltd Q2 FY27 Results

IRCONQ2 FY27 Results
Filing
Result:Poor· Market: Up#Margin squeeze#Base effect

Outlook: Cautiously Optimistic · Guidance: Cut

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue2.3K16.1%14.9%
Total Income2.4K15.7%11.9%
Expenditure2.2K15.3%11.9%
PBT170.7921.8%12.3%
Net Profit100.349.0%26.5%
OPM10.50%0.01pp3.36pp
NPM4.24%0.27pp2.22pp
EPS1.0910.1%25.9%
View full financials

Core infra metric (revenue) grew 14.9% but adjusted PAT fell 26.5% YoY on margin compression and a JV swing to loss, missing the company's own 6-7% PAT-margin guidance, so this is a growth-without-profit print capped below steady.

IRCON INTERNATIONAL · Q2 FY27 · THE VERDICT

Execution Quickens But Profit Slumps 26% — Margin Guidance Looks Untenable

IRCON's Q2 revenue jumped 14.9% YoY and execution accelerated 16.1% QoQ, the operational story looks solid. But PAT plummeted 26.5% YoY to ₹100 Cr (NPM just 4.2%) — contradicting management's 6–7% margin target by 260 basis points. The stock has repriced -69.6% from its ATH, reflecting the market's read: a business grinding through structural margin pressure despite headline growth.

06 Nov 2026 · 6 min read

The Quarter in One Tension

IRCON reported Q2 revenue of ₹2,272 Cr (+14.9% YoY, +16.1% QoQ) and operationally the company is moving: execution is accelerating, order book at ₹21,296 Cr (2.2x revenue) provides 9–12 months visibility, and EBITDA margins hit 10% — better than the 8–9% guided. The headline ought to read like a solid operational quarter. Except profit collapsed: PAT fell ₹26.5% YoY to ₹100 Cr, and the net margin compressed to just 4.2% — a full 260 basis points below management's reaffirmed guidance of 6–7%. This is not a timing miss. This is structural margin pressure meeting the tape.

Reported PAT (Q2)

₹100 Cr

NPM 4.2% | YoY −26.5%

Guided PAT margin

6–7%

Full-year reaffirmed

Gap

260 bps

Already mid-year, unresolved

Where the Profit Went

Management attributes the Q2 PAT miss to two one-offs: a ₹12–13 Cr tax hit from the Sri Lanka project completion, and a collapse in other income (legacy PPP dividend ended, new HAM projects still in construction, forex headwind on cash holdings). Fair points — these are non-recurring pressures. Adjust for them and underlying PAT might sit ~₹115–120 Cr, or roughly 5.0–5.3% margin. Still 90–140 bps short of the 6–7% target. The deeper issue: EBITDA at 10% is strong, but competitive bidding pressure (55% of the order book is on competitive bids) is compressing the path from EBITDA down to PAT. Other income and tax timing are icing; the cake is margin compression from operational intensity.

The reaffirmed 6–7% PAT margin guidance is now questionable. Even stripping one-offs, the data already contradicts it. Either management sees a sharp margin recovery in H2 (possible if higher-margin international orders are awarded), or the guidance is aspirational rather than grounded.

What Changed on This Call

Guidance and strategy shifts from prior call (FY26 Q2 earnings)
  • FY27 revenue guidance cut from ₹10,000–11,000 Cr to ₹9,000–9,500 Cr (−5% midpoint)

  • Order inflow target introduced at ₹9,000–10,000 Cr FY27; only ₹1,000 Cr won by Q2 (10% of target)

  • International order ambition raised from current 9% to target 15% of order book (Algeria, Africa, Eastern Europe)

  • PAT margin guidance reaffirmed at 6–7% despite Q2 delivery of 4.2%

Management's Claims vs. What Holds Up

How the call's key assertions reconcile with the numbers

Order book 2.2x annual revenue; competitive positioning intact

₹21,296 Cr ÷ ~₹9,500 Cr FY27 guidance = 2.24x; 55% competitive, 45% nomination-based

Supported

PAT margins will be 6–7% for full year (reaffirmed Q2 call)

Q2 delivered NPM 4.2% (₹100 Cr ÷ ₹2,272 Cr); YoY PAT −26.5% despite revenue +14.9%

Contradicted

EBITDA margins 8–9% consol basis

Q2 delivered OPM 10% (₹227 Cr EBITDA ÷ ₹2,272 Cr revenue)

Supported, exceeded

Targeting ₹9,000–10,000 Cr order inflows in FY27

Only ₹1,000 Cr new orders won by end Q2; need ₹8,000–9,000 Cr in H2 (high bar)

Overstated (10% of target achieved at midyear)

FY27 revenue ₹9,000–9,500 Cr (5–6% growth, down from prior 10,000–11,000 Cr)

H1 run-rate ~₹4,400 Cr annualizes to ~₹9,600–9,800 Cr; on track at midpoint of guidance

Supported (but downgraded from prior call)

The Bull-Bear Ledger

  • Execution momentum is real: Q2 QoQ +16.1% revenue growth shows operational delivery

  • Order book at 2.2x revenue; stable domestic (91%) and growing international (9% → 15% target)

  • EBITDA margins at 10% exceed guidance; underlying operating leverage intact

  • Sivok (₹2–2.5k Cr) and T-2 bullet train (₹3–3.5k Cr) execution ramping; large domestic railway/highway market opportunity (₹25k Cr quoted)

  • PAT -26.5% YoY despite revenue +14.9% — margin compression is structural, not one-time

  • Q2 NPM 4.2% vs 6–7% guided is a 260 bps miss; even adjusting for Sri Lanka tax and other income, underlying margin is ~5.0–5.3%

  • Order intake only ₹1,000 Cr of ₹9,000–10,000 Cr target by mid-year; H2 needs extreme acceleration

  • FY27 revenue guidance cut 5% midpoint from prior call; order inflow target only 10% achieved by Q2

  • 55% of order book on competitive bids; pricing power limited; PAT margin guidance unachievable without margin recovery or order mix shift

  • Subsidiary losses ongoing (coal connectivity ₹3.1k Cr+ invested, 2+ years to breakeven); capex deployment reducing interest income

Risks, Ranked by How Much They Should Concern a Holder

Margin compression unresolved

High

Q2 NPM 4.2% vs 6–7% guided is 260 bps; 55% of orders on competitive bidding; even adjusted for one-offs, underlying margin ~5.0–5.3%. Reaffirmed guidance looks untenable without order mix shift or dramatic H2 recovery.

Order intake shortfall

High

₹1,000 Cr won by Q2 vs ₹9,000–10,000 Cr annual target (10% achievement); need ₹8,000–9,000 Cr in H2 to hit guidance. ₹25k Cr quoted in domestic market awaiting opens, but conversion risk is real in competitive environment.

FY27 revenue miss

Medium

Downgraded from prior 10,000–11,000 Cr guidance to 9,000–9,500 Cr. H1 on track, but slow order intake increases H2 execution risk. If H2 orders don't materialize, full-year revenue will slip below ₹9,000 Cr.

Subsidiary losses drag ongoing

Medium

₹3,100+ Cr invested in coal connectivity JVs and HAM projects; still 2+ years to breakeven. Capital deployment reducing interest income. No near-term profit contribution; losses expected to reduce only gradually.

International expansion unproven

Medium

Bidding to shift international orders from 9% to 15% (Algeria, Africa, Eastern Europe). No track record of large-scale international contract execution. Geopolitical and execution risks unquantified; pitch is margin uplift, but delivery uncertain.

FY28 macro visibility absent

Medium

Management deferred FY28 guidance, citing 'volatile and sensitive market'. Without order inflow certainty for H2 FY27, forward visibility is opaque. Risk of further guidance cuts if H2 intake disappoints.

How the Street is Positioned

The market has already voted on this quarter. IRCON trades at ₹106.75, down −69.6% from its all-time high of ₹351.6, and is now trading below its SMA50 (₹108.89) and SMA200 (₹131.79) — a downtrend confirmed. The stock is +11.5% off the 52-week low of ₹95.76 but has ceded massive value. RSI at 54.4 is neutral — no extreme oversold condition, so further downside pressure is possible.

Institutional flows are negative. FII ownership fell from 4.78% (FY26 Q4) to 4.60% (FY27 Q1), a −18 bps pullback in this quarter. DII ownership is static at 1.79%. Promoter holding unchanged at 65.17%. The institutional trimming reflects a repricing: IRCON is being downgraded from a steady execution story to a business grinding through structural margin pressure. The vast drawdown (−69.6% from ATH) is the market's honest read — not a cyclical dip, but a fundamental repricing of earnings quality.

The street's verdict mirrors the fundamentals. Execution is accelerating but profit is decelerating; guidance was cut and is now at risk again; order intake is lagging; and margin recovery is no longer assumed. At a 2.24x order book multiple with deteriorating profitability and competitive intensity unabated, the stock is catching down to a lower earnings quality.

The Debate

What to Watch Next

The 2–3 things that resolve the debate
  • 1 · H2 order inflows: ₹8,000–9,000 Cr required

    Did IRCON win large orders in railways, highways, overseas markets? The ₹25k Cr quoted in domestic railways/highways is the opening. Failure to convert even ₹50% of it (₹12.5k Cr quoted, some wins expected) signals order intake is broken, not just slow.

  • 2 · Q3 PAT margin: Will it improve or slip further?

    If Q3 NPM stays below 5%, the 6–7% full-year guidance is unrealistic. Any margin recovery would need to show by Q3 to justify a full-year 6–7% claim. Flat or declining margins into Q4 would confirm structural compression.

  • 3 · International order awards and order book mix

    Is IRCON shifting from 9% international to 15%? Are the higher-margin international deals winning? This is the bull's last lever — but unproven. Large international contract awards (Algeria, Africa) would validate the strategy; a quiet H2 on this front raises execution risk.

Execution is quickening, but profit is slowing. This is not a cyclical quarter — it's a repricing of the business as margin-constrained and order-intake-lagging. The ₹4.2% PAT margin in Q2 vs the ₹6–7% guided is not noise; it's the new reality. Management is reaffirming guidance that the data has already contradicted. Without demonstrated margin recovery (not just hoped-for international order wins), the balance of risk is downside. The market's −69.6% drawdown from ATH reflects this honestly. The number to track from here is the organic PAT margin — if it stays below 5% into Q3, guidance is finished.

Informational and educational content only. Not investment advice.